Cited by 604Barrier Structure and Function StudiesNanoparticle-Based Drug DeliveryDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 234 of the 236 references it cites were found in a registry or an index.

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Open access

Xie, Jinbing, Shen, Zheyu, Anraku, Yasutaka, Kataoka, Kazunori, Chen, Xiaoyuan·2019·Biomaterials

DOI 10.1016/j.biomaterials.2019.119491PMC PMC6915305

Open this paper in CoChat — free account

Abstract

Increasing attention has been paid to the diseases of central nervous system (CNS). The penetration efficiency of most CNS drugs into the brain parenchyma is rather limited due to the existence of blood-brain barrier (BBB). Thus, BBB crossing for drug delivery to CNS remains a significant challenge in the development of neurological therapeutics. Because of the advantageous properties (e.g., relatively high drug loading content, controllable drug release, excellent passive and active targeting, good stability, biodegradability, biocompatibility, and low toxicity), nanomaterials with BBB-crossability have been widely developed for the treatment of CNS diseases. This review summarizes the current understanding of the physiological structure of BBB, and provides various nanomaterial-based BBB-crossing strategies for brain delivery of theranostic agents, including intranasal delivery, temporary disruption of BBB, local delivery, cell penetrating peptide (CPP) mediated BBB-crossing, receptor mediated BBB-crossing, shuttle peptide mediated BBB-crossing, and cells mediated BBB-crossing. Clinicians, biologists, material scientists and chemists are expected to be interested in this review.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2019.119491

Cites

234 of 234 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589
Retracted
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella‐Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,703
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,675
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,625
Convection-enhanced delivery of macromolecules in the brain.
Bobo, R. H., Laske, D. W., Akbaşak, A., Morrison, P. F., Dedrick, R. L., & Oldfield, E. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2076 · Cited by 1,442
Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 1,040
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,038
Cloning by functional expression of a member of the glutamate receptor family
Hollmann, M., O'Shea-Greenfield, A., Rogers, S. W., & Heinemann, S. F. (1989) · Nature · doi:10.1038/342643a0 · Cited by 1,016

Show all 236 references

Research works printed but not linked: 1

Feng, 2017, Self-assembly of gold nanoparticles shows microenvironment-mediated dynamic switching and enhanced brain tumor targeting, Theranostics, 7, 1875, 10.7150/thno.18985 · DOI

Sorted by citations

The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
Self-citation
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Narayanan, J., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,132
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Montoto, S. S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 695
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641
Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies
Ding, S., Khan, A. I., Cai, X., Song, Y., Lyu, Z., Du, D., Dutta, P., & Lin, Y. (2020) · Materials Today · doi:10.1016/j.mattod.2020.02.001 · Cited by 468
Pathophysiology of Blood–Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery
Bernardo-Castro, S., Sousa, J. A., Brás, A., Cecília, C., Rodrigues, B., Almendra, L., Machado, C., Santo, G., da Silva, F. A. D. A., Ferreira, L., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.594672 · Cited by 395
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024) · ACS Nano · doi:10.1021/acsnano.3c10674 · Cited by 378
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U. D., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.044 · Cited by 304
Blood–Spinal Cord Barrier in Spinal Cord Injury: A Review
Jin, L., Li, J., Wang, K., Xia, W., Zhu, Z., Wang, C., Li, X., & Liu, H. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7413 · Cited by 301
Macrophage Membrane-Camouflaged Responsive Polymer Nanogels Enable Magnetic Resonance Imaging-Guided Chemotherapy/Chemodynamic Therapy of Orthotopic Glioma
Xiao, T., He, M., Xu, F., Fan, Y., Jia, B., Shen, M., Wang, H., & Shi, X. (2021) · ACS Nano · doi:10.1021/acsnano.1c08689 · Cited by 231
Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1/M2 microglial polarization in an Alzheimer's disease model
Ren, C., Li, D., Zhou, Q., & Hu, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119752 · Cited by 229
Camouflaging Nanoparticles with Brain Metastatic Tumor Cell Membranes: A New Strategy to Traverse Blood–Brain Barrier for Imaging and Therapy of Brain Tumors
Wang, C., Wu, B., Wu, Y., Song, X., Zhang, S., & Liu, Z. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909369 · Cited by 217
Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
Choi, J., Kim, G., Cho, S. B., & Im, H. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00684-5 · Cited by 205
Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
Gu, W., Meng, F., Haag, R., & Zhong, Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.003 · Cited by 198
Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
Mitusova, K. A., Peltek, O. O., Karpov, T. E., Muslimov, A. R., Zyuzin, M. V., & Timin, A. S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01610-7 · Cited by 193
Recent progress in NIR-II fluorescence imaging-guided drug delivery for cancer theranostics
Roy, S., Bag, N., Bardhan, S., Hasan, I., & Guo, B. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114821 · Cited by 188
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Moradi, S. Z., Momtaz, S., Bayrami, Z., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00238 · Cited by 187
Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases
Masoudi Asil, S., Ahlawat, J., Guillama Barroso, G., & Narayan, M. (2020) · Biomaterials Science · doi:10.1039/d0bm00809e · Cited by 181
Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment
Zou, Y., Sun, Y., Wang, Y., Zhang, D., Yang, H., Wang, X., Zheng, M., & Shi, B. (2023) · Nature Communications · doi:10.1038/s41467-023-40280-3 · Cited by 192
An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy
Lu, L., Zhao, X., Fu, T., Li, K., He, Y., Luo, Z. Y., Dai, L., Zeng, R., & Cai, K. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119666 · Cited by 180
Nanotechnology-based drug delivery for central nervous system disorders
Nguyen, T. T., Nguyen, T. T. D., Vo, T. K., An, T. N. M., Nguyen, M. K., Toi, V. V., & Vo, G. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112117 · Cited by 182
Targeting pyroptosis as a preventive and therapeutic approach for stroke
Long, J., Sun, Y., Liu, S., Yang, S., Chen, C., Zhang, Z., Chu, S., Yang, Y., Pei, G., Lin, M., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01440-y · Cited by 158
Neurobiological effects of gallic acid: current perspectives
Bhuia, M. S., Rahaman, M. M., Islam, T., Bappi, M. H., Sikder, M. I., Hossain, K. N., Akter, F., Prottay, A. A. S., Rokonuzzman, M., Gürer, E. S., et al. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00735-7 · Cited by 163
Intelligent Micro‐/Nanorobots for Cancer Theragnostic
Wang, J., Dong, Y., Ma, P., Wang, Y., Zhang, F., Cai, B., Chen, P., & Liu, B. (2022) · Advanced Materials · doi:10.1002/adma.202201051 · Cited by 142
Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases
Zhang, Y., Yang, H. N., Wei, D., Zhang, X., Wang, J., Wu, X., & Chang, J. K. (2021) · Exploration · doi:10.1002/exp.20210115 · Cited by 136
Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor
Liu, H., & Xu, P. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114619 · Cited by 136
Blood–brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders
Alajangi, H. K., Kaur, M., Sharma, A., Rana, S., Thakur, S., Chatterjee, M., Singla, N., Jaiswal, P. K., Singh, G., & Barnwal, R. P. (2022) · Molecular Brain · doi:10.1186/s13041-022-00937-4 · Cited by 137
Smart Nanomedicine to Enable Crossing Blood–Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma
Wang, H., Chao, Y., Zhao, H., Zhou, X., Zhang, F., Zhang, Z., Li, Z., Pan, J., Wang, J., Chen, Q., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c08120 · Cited by 118
Progress in cancer drug delivery based on AS1411 oriented nanomaterials
Tong, X., Ga, L., Ai, J., & Wang, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01240-z · Cited by 125
An update on actively targeted liposomes in advanced drug delivery to glioma
Mojarad-Jabali, S., Farshbaf, M., Walker, P. R., Hemmati, S., Fatahi, Y., Zakeri‐Milani, P., Sarfraz, M., & Valizadeh, H. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120645 · Cited by 117
Gut-Brain Axis: Role of Microbiome, Metabolomics, Hormones, and Stress in Mental Health Disorders
Verma, A., Inslicht, S. S., & Bhargava, A. (2024) · Cells · doi:10.3390/cells13171436 · Cited by 137
Development of curcumin-loaded zein nanoparticles for transport across the blood–brain barrier and inhibition of glioblastoma cell growth
Zhang, H., van Os, W. L., Tian, X., Zu, G., Ribovski, L., Bron, R., Bussmann, J., Kros, A., Liu, Y., & Zuhorn, I. S. (2021) · Biomaterials Science · doi:10.1039/d0bm01536a · Cited by 112
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
Zhang, Z., Xu, X., Du, J., Chen, X., Xue, Y., Zhang, J., Yang, X., Chen, X. S., Xie, J., & Ju, S. (2024) · Nature Communications · doi:10.1038/s41467-024-44963-3 · Cited by 111
Self-citation
How Nanoparticles Open the Paracellular Route of Biological Barriers: Mechanisms, Applications, and Prospects
Wu, J., Zhu, Z., Liu, W., Zhang, Y., Kang, Y., Liu, J., Hu, C., Wang, R., Zhang, M., Chen, L., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c05317 · Cited by 110
Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration
Wang, J., Ni, Q., Wang, Y., Zhang, Y., He, H., Gao, D., Ma, X., & Liang, X. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.045 · Cited by 103
Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain
Wu, J. R., Hernández, Y. M., Miyasaki, K. F., & Kwon, E. J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114820 · Cited by 108
Focusing on mitochondria in the brain: from biology to therapeutics
Song, N., Mei, S., Wang, X.-X., Hu, G., & Lu, M. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00409-w · Cited by 111
Biosensors integrated 3D organoid/organ-on-a-chip system: A real-time biomechanical, biophysical, and biochemical monitoring and characterization
Liu, S., Kumari, S., He, H., Mishra, P., Singh, B. N., Singh, D., Liu, S., Srivastava, P., & Li, C. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115285 · Cited by 103
Role of pyroptosis in the pathogenesis of various neurological diseases
Oladapo, A., Jackson, T., Menolascino, J., & Periyasamy, P. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.001 · Cited by 101
Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood–Brain Barrier by Using Different Transport Mechanisms
Song, J., Lu, C. T., Leszek, J., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810118 · Cited by 97
Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma
Shen, Z., Liu, T., Yáng, Z., Zhou, Z., Tang, W., Fan, W., Liu, Y., Mu, J., Li, L., Bregadze, V. I., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119783 · Cited by 96
Self-citation
The application of exosomes and Exosome-nanoparticle in treating brain disorders
Salarpour, S., Barani, M., Pardakhty, A., Khatami, M., & Chauhan, N. P. S. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.118549 · Cited by 92
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Mallick, R., Basak, S., Chowdhury, P., Bhowmik, P., Das, R. K., Banerjee, A., Paul, S., Pathak, S., & Duttaroy, A. K. (2025) · Pharmaceuticals · doi:10.3390/ph18010104 · Cited by 108
Advances in drug delivery technology for the treatment of glioblastoma multiforme
Cha, G. D., Kang, T., Baik, S., Kim, D., Choi, S., Hyeon, T., & Kim, D.-H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.002 · Cited by 96
Neisseria meningitidis Opca Protein/MnO2 Hybrid Nanoparticles for Overcoming the Blood–Brain Barrier to Treat Glioblastoma
Dong, C., Huang, Q., Cheng, H. L., Zheng, D., Hong, S., Yan, Y. Q., Niu, M., Xu, J., & Zhang, X. (2022) · Advanced Materials · doi:10.1002/adma.202109213 · Cited by 90
Biodistribution, degradability and clearance of 2D materials for their biomedical applications
Fan, T., Yan, L., He, S., Hong, Q., Ai, F., He, S., Ji, T., Hu, X., Ha, E., Zhang, B., et al. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01070k · Cited by 90
Self-citation
The Relationship between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors
Dong, M., Wen, S., & Zhou, L. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s375559 · Cited by 90
Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review
Zhang, Y., Guo, P., Ma, Z., Lü, P., Kebebe, D., & Liu, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01002-3 · Cited by 92
Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases
Li, J., Wei, Y., Zhang, C., Bi, R., Qiu, Y., Li, Y., & Hu, B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020621 · Cited by 85
Nanomaterials toward the treatment of Alzheimer’s disease: Recent advances and future trends
Zeng, H., Qi, Y., Zhang, Z., Liu, C., Peng, W., & Zhang, Y. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.01.014 · Cited by 83
BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment
Chen, W., Yao, S., Wan, J., Tian, Y., Huang, L., Wang, S., Akter, F., Wu, Y., Yao, Y., & Zhang, X. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.029 · Cited by 81
PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study
Hoyos-Ceballos, G. P., Ruozi, B., Ottonelli, I., da Ros, F., Vandelli, M., Forni, F., Daini, E., Vilella, A., Zoli, M., Tosi, G., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010072 · Cited by 77
In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
Costa, C. P., Barreiro, S., Moreira, J. N., Silva, R. V. D. S., Almeida, H., Lobo, J. M. S., & Silva, A. C. (2021) · Pharmaceuticals · doi:10.3390/ph14080711 · Cited by 86
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
Luo, M., Lee, L. K. C., Peng, B., Choi, C. H. J., Tong, W. Y., & Voelcker, N. H. (2022) · Advanced Science · doi:10.1002/advs.202201740 · Cited by 85
Overcoming the Blood–Brain Barrier for Gene Therapy via Systemic Administration of GSH‐Responsive Silica Nanocapsules
Wang, Y., Wang, X., Xie, R., Burger, J. C., Tong, Y., & Gong, S. (2022) · Advanced Materials · doi:10.1002/adma.202208018 · Cited by 84
Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy
Wang, L., Shi, Y., Jiang, J., Li, C., Zhang, H., Zhang, X., Jiang, T., Wang, L., Wang, Y., & Feng, L. (2022) · Small · doi:10.1002/smll.202203678 · Cited by 71
An NIR-Driven Upconversion/C3N4/CoP Photocatalyst for Efficient Hydrogen Production by Inhibiting Electron–Hole Pair Recombination for Alzheimer’s Disease Therapy
Ge, K., Li, Z., Wang, A., Bai, Z., Zhang, X., Zheng, X., Liu, Z., & Gao, F. (2023) · ACS Nano · doi:10.1021/acsnano.2c08499 · Cited by 83
FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA
Geng, Y., Long, X., Zhang, Y., Wang, Y., You, G., Guo, W., Zhang, Y., Zhang, Y., Cheng, X., Yuan, Z., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04461-4 · Cited by 83
Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
Çiftçi, F., Özarslan, A. C., Kantarci, İ. C., Yelkenci, A., Tavukçuoğlu, Ö., & Ghorbanpour, M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010121 · Cited by 92
Near-Infrared Radiation-Assisted Drug Delivery Nanoplatform to Realize Blood–Brain Barrier Crossing and Protection for Parkinsonian Therapy
Liu, Y., Hong, H., Xue, J., Luo, J., Liu, Q., Chen, X., Pan, Y., Zhou, J., Liu, Z., & Chen, T. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c12675 · Cited by 75
Self-citation
Anti-inflammatory potential of quercetin: From chemistry and mechanistic insight to nanoformulations
Aggarwal, D., Chaudhary, M., Mandotra, S. K., Tuli, H. S., Chauhan, R., Joshi, N. C., Kaur, D., Dufossé, L., & Chauhan, A. P. S. (2025) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2025.100217 · Cited by 85
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Taliyan, R., Kakoty, V., Sarathlal, K. C., Kharavtekar, S. S., Karennanavar, C. R., Choudhary, Y. K., Singhvi, G., Riadi, Y., Dubey, S. K., & Kesharwani, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.044 · Cited by 79
Lipid nanoparticles for mRNA delivery in brain via systemic administration
Cao, D., Hou, X., Wang, C., Wang, S., Liu, Z., Tian, M., Guo, K., Li, H., Kang, D. D., Zhong, Y., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw0730 · Cited by 79
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
Pandey, N., Anastasiadis, P., Carney, C. P., Kanvinde, P. P., Woodworth, G. F., Winkles, J. A., & Kim, A. J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114415 · Cited by 74
Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment
Lu, X., Zhang, Y., Wang, L., Li, G., Gao, J., & Wang, Y. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1883158 · Cited by 68
Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer
Cai, X., Drummond, C. J., Zhai, J., & Tran, N. L. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202404234 · Cited by 75
Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
Zhuang, D., Zhang, H., Hu, G., & Guo, B. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01479-6 · Cited by 66
Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancer
Mojarad-Jabali, S., Mahdinloo, S., Farshbaf, M., Sarfraz, M., Fatahi, Y., Atyabi, F., & Valizadeh, H. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2083106 · Cited by 69
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Saha, P., Kathuria, H., & Pandey, M. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.021 · Cited by 67
Low intensity focused ultrasound: a new prospect for the treatment of Parkinson’s disease
Zhong, Y., Liao, J., Liu, X., Tian, H., Deng, L.-R., & Long, L. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2251145 · Cited by 64
Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation
Shao, X., Yan, C., Wang, C., Wang, C., Cao, Y. Q., Zhou, Y., Guan, P., Hu, X., Zhu, W., & Ding, S. (2022) · Nanoscale Advances · doi:10.1039/d2na00625a · Cited by 63
Damage mechanism and therapy progress of the blood-brain barrier after ischemic stroke
Gao, H., Chen, H., Cui, G.-Y., & Hu, J.-X. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01126-z · Cited by 68
Platelet-derived extracellular vesicles ameliorate intervertebral disc degeneration by alleviating mitochondrial dysfunction
Dai, Z., Xia, C., Zhao, T., Wang, H., Tian, H., Xu, O., Zhu, X., Zhang, J., & Chen, P. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100512 · Cited by 62
Recent advances of engineering cell membranes for nanomedicine delivery across the blood–brain barrier
Yuan, S., Hu, D., Gao, D., Butch, C. J., Wang, Y., Zheng, H., & Sheng, Z. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03572-y · Cited by 70
Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood–Brain Barrier Transmitters
Amiri, M., Jafari, S., Kurd, M., Mohamadpour, H., Khayati, M., Ghobadinezhad, F., Tavallaei, O., Derakhshankhah, H., Malvajerd, S. S., & Izadi, Z. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00540 · Cited by 61
Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma
Luo, H., Zhang, H., Mao, J., Cao, H., Tao, Y., Zhao, G., Zhang, Z., Zhang, N., Liu, Z., Zhang, J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05753-9 · Cited by 63
Hemorrhagic Conversion of Acute Ischemic Stroke
Zubair, A. S., & Sheth, K. N. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01377-1 · Cited by 65
Target-driven supramolecular self-assembly for selective amyloid-β photooxygenation against Alzheimer's disease
Liu, Z., Ma, M., Yu, D., Ren, J., & Qu, X. (2020) · Chemical Science · doi:10.1039/d0sc04984k · Cited by 61
Micro/nanosystems for controllable drug delivery to the brain
Tian, M., Ma, Z., & Yang, G. (2023) · The Innovation · doi:10.1016/j.xinn.2023.100548 · Cited by 64
Biomarker-activated multifunctional lysosome-targeting chimeras mediated selective degradation of extracellular amyloid fibrils
Liu, Z., Deng, Q., Qin, G., Yang, J., Zhang, H., Ren, J., & Qu, X. (2023) · Chem · doi:10.1016/j.chempr.2023.06.003 · Cited by 59
Neutrophil-Biomimetic “Nanobuffer” for Remodeling the Microenvironment in the Infarct Core and Protecting Neurons in the Penumbra via Neutralization of Detrimental Factors to Treat Ischemic Stroke
Liu, S., Xu, J., Liu, Y., You, Y., Xie, L., Tong, S., Chen, Y., Liang, K., Zhou, S., Li, F., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c09020 · Cited by 58
Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds
Zhang, Y., He, J., Shen, L., Wang, T., Yang, J., Li, Y., Wang, Y., & Quan, D. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.039 · Cited by 59
Low-Intensity Focused Ultrasound Technique in Glioblastoma Multiforme Treatment
Mungur, R., Zheng, J.-S., Wang, B., Chen, X., Zhan, R., & Tong, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.903059 · Cited by 59
Self-citation
Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier
Khan, M. S., Mohapatra, S., Gupta, V., Ali, A., Naseef, P. P., Kuruniyan, M. S., Alshadidi, A. A. F., Alam, M. S., Mirza, M. A., & Iqbal, Z. (2023) · Membranes · doi:10.3390/membranes13030343 · Cited by 57
Magnetic Particle Imaging: From Tracer Design to Biomedical Applications in Vasculature Abnormality
Xie, X., Zhai, J., Zhou, X., Guo, Z., Lo, P., Zhu, G., Chan, K. W. Y., & Yang, M. (2023) · Advanced Materials · doi:10.1002/adma.202306450 · Cited by 57
Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
Liao, J., He, W., Li, L., Wang, J., Gong, L., Zhang, Q., & Lin, Z. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100016 · Cited by 63
Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance
Rhaman, M. M., Islam, M. R., Akash, S., Mim, M., Noor alam, M., Nepovimova, E., Valis, M., Kuca, K., & Sharma, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.989471 · Cited by 63
Nanotechnology-based herbal medicine: Preparation, synthesis, and applications in food and medicine
Awlqadr, F. H., Majeed, K. R., Altemimi, A. B., Hassan, A. M. A., Qadir, S. A., Saeed, M. N., Faraj, A. M., Salih, T. H., Al‐Manhel, A. J. A., Najm, M. A. A., et al. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.101661 · Cited by 67
Patient‐derived xenograft models in pan‐cancer: From bench to clinic
Li, J., Gu, A., Tang, N., Zengin, G., Li, M., & Liu, Y. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.20250016 · Cited by 62
Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis
Li, H., Ding, Y., Huang, J., Zhao, Y., Chen, W., Tang, Q., An, Y., Chen, R., & Hu, C. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s395246 · Cited by 57
Stroke-induced damage on the blood–brain barrier
Xue, S., Zhou, X., Yang, Z., Si, X., & Sun, X. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1248970 · Cited by 58
An Engineered Nanoplatform with Tropism Toward Irradiated Glioblastoma Augments Its Radioimmunotherapy Efficacy
Wang, Z., Chen, F., Cao, Y., Zhang, F., Sun, L., Yang, C., Xie, X., Wu, Z., Sun, M., Ma, F., et al. (2024) · Advanced Materials · doi:10.1002/adma.202314197 · Cited by 57
Biomimetic and cell-based nanocarriers – New strategies for brain tumor targeting
Mendanha, D., de Castro, J. V., Ferreira, H., & Neves, N. M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.047 · Cited by 56
Brain Delivery of Biomimetic Phosphorus Dendrimer/Antibody Nanocomplexes for Enhanced Glioma Immunotherapy via Immune Modulation of T Cells and Natural Killer Cells
Peng, Y., Zhan, M., Karpus, A. O., Zou, Y., Mignani, S. M., Majoral, J., Shi, X., & Shen, M. (2024) · ACS Nano · doi:10.1021/acsnano.3c13088 · Cited by 54
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Jang, Y.-J., Kang, S.-J., Park, H. S., Lee, D., Kim, J. H., Kim, J.-E., Kim, D., Chung, C., Yoon, J., & Bhang, S. H. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03109-3 · Cited by 64
Micelleplexes as nucleic acid delivery systems for cancer-targeted therapies
Pereira‐Silva, M., Jarak, I., Alvarez‐Lorenzo, C., Concheiro, Á., Paiva‐Santos, A. C., Veiga, F., & Figueiras, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.041 · Cited by 56
Promoting Reactive Oxygen Species Generation: A Key Strategy in Nanosensitizer-Mediated Radiotherapy
Jia, S., Ge, S., Fan, X., Leong, K. W., & Ruan, J. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0448 · Cited by 56
Macrophage–Cancer Hybrid Membrane-Camouflaged Nanoplatforms for HIF-1α Gene Silencing-Enhanced Sonodynamic Therapy of Glioblastoma
Li, Y., Liu, Y., Xu, J., Chen, D., Wu, T., & Cao, Y. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c03001 · Cited by 52
Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders
Persano, F., Batasheva, S., Fakhrullina, G., Gigli, G., Leporatti, S., & Fakhrullin, R. F. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02957b · Cited by 54

Authors: Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X.
Affiliations: Innovation Center of NanoMedicine (JP)
National Institutes of Health (US)
Corresponding author: Shen, Zheyu
Kataoka, Kazunori
Chen, Xiaoyuan
ORCID: Xie, Jinbing
Shen, Zheyu
Anraku, Yasutaka
Kataoka, Kazunori
Chen, Xiaoyuan
Venue: Biomaterials
Publisher: Elsevier BV
Published: 2019-12
Volume: 224
Pages: 119491
ISSN: 0142-9612 (ISSN-L)
DOI: 10.1016/j.biomaterials.2019.119491
PMC: PMC6915305
OpenAlex: W2973160898
Cited by: 604
References: 236
Citations by year: 2026: 64 · 2025: 131 · 2024: 116 · 2023: 104 · 2022: 92 · 2021: 57 · 2020: 38 · 2019: 2
FWCI: 4.92
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Biomaterials (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: blood-brain barrier, BBB crossing, nanomaterials, brain drug delivery, central nervous system disorders, intranasal drug delivery, blood-brain barrier disruption, cell-penetrating peptides, receptor-mediated transcytosis, theranostic agents
MeSH terms: Animals, Blood-Brain Barrier, Central Nervous System Diseases, Clinical Trials as Topic, Disease Models, Animal, Humans, Drug Delivery Systems, Nanostructures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks